|Bid||26.05 x 0|
|Ask||26.40 x 0|
|Day's range||25.81 - 26.14|
|52-week range||20.30 - 27.44|
|PE ratio (TTM)||7.63|
|Earnings date||20 Aug. 2018|
|Forward dividend & yield||0.61 (2.28%)|
|1y target est||20.33|
Protective gloves and clothing supplier Ansell has lifted its full-year outlook for earnings per share from its continuing businesses and says it is well positioned for growth. Chief executive Magnus Nicolin says Ansell is seeing strong growth in its HyFlex range of industrial gloves and its Gammex surgical gloves as the products are upgraded with new materials and combinations of materials made by Ansell. Ansell also has invested heavily in products for the life sciences and pharmaceutical manufacturing sectors.
Protective gloves and clothing supplier Ansell has lifted its full-year outlook for earnings per share from its continuing businesses to a range of 96 US cents to $US1.06, ($A1.23 to ($A1.37) up from its previous expectation of 91 US cents to $US1.01. Ansell says the lift in guidance relates to the company's share buyback to date and a lower tax expense following US tax reform, plus the group's underlying business is performing in line with original forecasts. Ansell on Monday reported a net profit of $US428.2 million ($A547.97 million) for the six months to December 31 - up more than 500 per cent - after the company benefited from a $US411.5 million gain on the sale of its sexual wellness business.
Protective gloves and clothing supplier Ansell says growth momentum from 2016/17 has continued into the first three months of the current financial year. The company has maintained its guidance for underlying earnings per share from its continuing businesses of 91 to 101 US cents in fiscal 2018. Adding the benefits so far from an ongoing share buyback, and earnings from Ansell's former condoms business before the completion of its $US600 million sale in September, total earnings per share are expected to be between 95 and 105 US cents for the year.